OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Residual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence
Diana A. Putavet, Peter L.J. de Keizer
Cancers (2021) Vol. 13, Iss. 7, pp. 1560-1560
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion
Emerson De Fazio, Matilde Pittarello, Alessandro Gans, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2563-2563
Open Access | Times Cited: 15

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis
Rebeca Uceda-Castro, Andreia S. Margarido, Lesley Cornet, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 11, pp. 100821-100821
Open Access | Times Cited: 30

Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers
Lloyd A. Greene, Qing Zhou, Markus D. Siegelin, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 581-581
Open Access | Times Cited: 18

VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance
Cathy Pichol-Thievend, Océane Anezo, Aafrin M. Pettiwala, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

CD44 Depletion in Glioblastoma Cells Suppresses Growth and Stemness and Induces Senescence
Constantinos Kolliopoulos, Mohamad Moustafa Ali, Casimiro Castillejo-López, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3747-3747
Open Access | Times Cited: 20

Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
Cristian Ionuț Orășanu, Mariana Aşchie, Mariana Deacu, et al.
Diagnostics (2025) Vol. 15, Iss. 4, pp. 438-438
Open Access

EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms
Bo Fan, Qing Pan, Xiaokai Yuan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access

Optical Methods for Brain Tumor Detection: A Systematic Review
Gustav Burström, Misha Amini, Victor Gabriel El-Hajj, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2676-2676
Open Access | Times Cited: 2

The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients’ Lymphocytes Favoring Chemotherapy Efficacy
Annibale Alessandro Puca, Valentina Lopardo, Francesco Montella, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 10

Modelling the dynamics of senescence spread
Lucy Martin, Linus J. Schumacher, Tamir Chandra
Aging Cell (2023) Vol. 22, Iss. 8
Open Access | Times Cited: 5

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
Junsheng Li, Jia Wang, Dongjing Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8

Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma
Jianhua Mu, Jianan Gong, Miao Shi, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Immunotherapeutic advances in glioma management: The rise of vaccine‐based approaches
Wireko Andrew Awuah, Muhammad Hamza Shah, Joecelyn Kirani Tan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 9
Open Access | Times Cited: 1

Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
Saidu Sani, Nikita Pallaoro, Melissa Messé, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 369-369
Open Access | Times Cited: 7

Role of stress granules in modulating senescence and promoting cancer progression: Special emphasis on glioma
Debmita Chatterjee, Oishee Chakrabarti
International Journal of Cancer (2021) Vol. 150, Iss. 4, pp. 551-561
Open Access | Times Cited: 8

Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas
Yang Yang, Xin Chen, Jianjun Sun, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 6

Machine learning recognises senescence in glioblastoma and discovers senescence-inducing compounds
Lucy Martin, Anna Irving, Yossawat Suwanlikit, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines
Kanokkuan Somrit, Sucheewin Krobthong, Yodying Yingchutrakul, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines
Kanokkuan Somrit, Sucheewin Krobthong, Yodying Yingchutrakul, et al.
Life Sciences (2024), pp. 123132-123132
Closed Access

Ready for Prime Time? Dendritic Cells in High-Grade Gliomas
Claire Ann Conarroe, Timothy N. J. Bullock
Cancers (2023) Vol. 15, Iss. 11, pp. 2902-2902
Open Access | Times Cited: 1

Cell aging-related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas
Yang Yang, Xin Chen, Hongbin Han, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1

Therapeutic Hypothermia in Treating Glioblastoma: A Review
Athina Malliou, Chrysoula Mitsiou, Athanasios P. Kyritsis, et al.
Therapeutic Hypothermia and Temperature Management (2023) Vol. 14, Iss. 1, pp. 2-9
Closed Access

Page 1 - Next Page

Scroll to top